Literature DB >> 8751255

Nitric oxide release during hypothermic versus normothermic cardiopulmonary bypass.

G Ruvolo1, G Speziale, E Greco, L Tritapepe, V Mollace, G Nistico, B Marino.   

Abstract

Cardiopulmonary bypass (CPB) produces hemodynamic and inflammatory disorders involving changes in vascular permeability and regional blood flow and alterations of coagulation and complement systems. It has been reported that an abnormal release of vasoactive substances during CPB, like bradykinin or nitric oxide, could play a role. The aim of this study was to investigate the changes in nitric oxide (NO) release occurring in patients undergoing CPB, under both hypothermic and normothermic conditions. Forty patients (mean age 61.4 +/- 8.4 years) undergoing coronary bypass surgery were studied. In 20 patients (group A) systemic hypothermic CPB and antegrade cold intermittent crystalloid cardioplegia were used. The remaining 20 cases (group B) underwent surgery under systemic normothermic CPB and with antegrade warm blood intermittent cardioplegia. Nitric oxide was measured as the nitrite plasma level (NPL) by the Gries reaction. The time course of changes in NPL were obtained by collecting five whole blood samples: before CPB, 10 and 30 min after the start of CPB, and 10 and 60 min after the end of CPB. Although there were no significant variations of NPL shortly after the start of CPB (10 min after), values measured 30 min after CPB commencement and 10 min after the end of CPB showed a significant increase (P < 0.0001) in both groups. Considering the two groups separately, NPL changes seemed to be similar, so independent of temperature; however, in group B higher values of NPL were measured during (30 min) and after (60 min) CPB (P < 0.0001). In conclusion, during CPB there is a progressive increase, independent of temperature in NO release.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8751255     DOI: 10.1016/s1010-7940(05)80112-5

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  Effect of myocardial reperfusion on the release of nitric oxide after regional ischemia: an experimental model of beating-heart surgery.

Authors:  Koki Nakamura; Sharif Al-Ruzzeh; Caroline Gray; Magdi Yacoub; Mohamed Amrani
Journal:  Tex Heart Inst J       Date:  2006

2.  Effects of tranexamic acid and aprotinin, two antifibrinolytic drugs, on PAF-induced plasma extravasation in unanesthetized rats.

Authors:  J G O'Brien; B Battistini; F Zaharia; G E Plante; P Sirois
Journal:  Inflammation       Date:  2000-10       Impact factor: 4.092

3.  Organ-protective effects on the liver and kidney by minocycline in small piglets undergoing cardiopulonary bypass.

Authors:  Stefan Dhein; Maria Grassl; Maria Gerdom; Marcel Vollroth; Farhad Bakhtiary; Sandy von Salisch; Klaus Krämer; Axel Sobiraj; Martin Kostelka; Friedrich-Wilhelm Mohr; Aida Salameh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-03-17       Impact factor: 3.000

4.  Case Report: Emergency CABG Following Failure of PTCA in a COVID-19 Patient.

Authors:  Silvia Romiti; Marco Totaro; Amalia Laderchi; Mariangela Peruzzi; Mattia Vinciguerra; Ernesto Greco
Journal:  Front Cardiovasc Med       Date:  2021-01-11

Review 5.  The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.

Authors:  Olga Papazisi; Meindert Palmen; A H Jan Danser
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-21       Impact factor: 3.947

6.  Volatile anesthetic preconditioning modulates oxidative stress and nitric oxide in patients undergoing coronary artery bypass grafting.

Authors:  Sathish Kumar Dharmalingam; G Jayakumar Amirtharaj; Anup Ramachandran; Mary Korula
Journal:  Ann Card Anaesth       Date:  2021 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.